![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
CJ Heyser, RE Hampson and SA Deadwyler
Department of Physiology and Pharmacology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina.
The effects of delta-9-tetrahydrocannabinol (delta-9-THC) were studied during performance of a delayed match to sample (DMTS) task in rats. Correlated hippocampal cellular activity was also assessed in terms of the effects of cannabinoids on well characterized task specific changes in firing rate which occurred during various phases of a DMTS trial. Results show a surprising correlation between the delay and dose (0.75- 2.0 mg/kg)-dependent behavioral deficit produced by delta-9-THC in this task and similar effects produced by damage to the hippocampus and related structures. However, unlike the effects of hippocampal lesions or neurotoxic damage, the effects of delta-9-THC were completely reversible within 24 hr of injection. Neither control injection of the vehicle nor equivalent concentrations of the nonpsychoactive cannabinoid, cannabidiol, produced alterations in DMTS performance levels. Simultaneous recordings from identified hippocampal complex spike cells at the highest dose of drug indicated that the DMTS deficit was associated with a specific decrease in hippocampal cell discharge during the Sample (but not the Match) phase of the task. In nine identified neurons (including four observed during both control and drug conditions) recorded from six different animals in which the effects of delta-9-THC were manifested, no indication of Sample phase firing was observed. Although there were slight but significant reductions in Match and Reinforcement phase related firing during THC sessions, highly significant increases in firing in these phases were still present, indicating that elimination of Sample phase firing did not reflect a nonspecific effect of delta-9-THC on hippocampal cell activity. These findings strongly suggest that performance of the DMTS task was selectively impaired by the lack of Sample phase discharge of hippocampal neurons during the DMTS trial, and that this effect could serve as the basis for the well characterized short-term memory and other cognitive deficits reported in humans after smoking marijuana.
This article has been cited by other articles:
|
|
 |
|
  F. Niyuhire, S. A. Varvel, B. R. Martin, and A. H. Lichtman Exposure to Marijuana Smoke Impairs Memory Retrieval in Mice J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1067 - 1075. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Sim-Selley, N. S. Schechter, W. K. Rorrer, G. D. Dalton, J. Hernandez, B. R. Martin, and D. E. Selley Prolonged Recovery Rate of CB1 Receptor Adaptation after Cessation of Long-Term Cannabinoid Administration Mol. Pharmacol., September 1, 2006; 70(3): 986 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Varvel, B. F. Cravatt, A. E. Engram, and A. H. Lichtman Fatty Acid Amide Hydrolase (-/-) Mice Exhibit an Increased Sensitivity to the Disruptive Effects of Anandamide or Oleamide in a Working Memory Water Maze Task J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 251 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Hampson, S.-y. Zhuang, J. L. Weiner, and S. A. Deadwyler Functional Significance of Cannabinoid-Mediated, Depolarization-Induced Suppression of Inhibition (DSI) in the Hippocampus J Neurophysiol, July 1, 2003; 90(1): 55 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. F. FREUND, I. KATONA, and D. PIOMELLI Role of Endogenous Cannabinoids in Synaptic Signaling Physiol Rev, July 1, 2003; 83(3): 1017 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Howlett, F. Barth, T. I. Bonner, G. Cabral, P. Casellas, W. A. Devane, C. C. Felder, M. Herkenham, K. Mackie, B. R. Martin, et al. International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors Pharmacol. Rev., June 1, 2002; 54(2): 161 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ohno-Shosaku, H. Tsubokawa, I. Mizushima, N. Yoneda, A. Zimmer, and M. Kano Presynaptic Cannabinoid Sensitivity Is a Major Determinant of Depolarization-Induced Retrograde Suppression at Hippocampal Synapses J. Neurosci., May 15, 2002; 22(10): 3864 - 3872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Breivogel, G. Griffin, V. Di Marzo, and B. R. Martin Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain Mol. Pharmacol., July 1, 2001; 60(1): 155 - 163. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. Slikker Jr., B. D. Beck, D. A. Cory-Slechta, M. G. Paule, W. K. Anger, and D. Bellinger Cognitive Tests: Interpretation for Neurotoxicity? (Workshop Summary) Toxicol. Sci., December 1, 2000; 58(2): 222 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Hampson and S. A. Deadwyler Cannabinoids Reveal the Necessity of Hippocampal Neural Encoding for Short-Term Memory in Rats J. Neurosci., December 1, 2000; 20(23): 8932 - 8942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. KITTLER, E. V. GRIGORENKO, C. CLAYTON, S.-Y. ZHUANG, S. C. BUNDEY, M. M. TROWER, D. WALLACE, R. HAMPSON, and S. DEADWYLER Large-scale analysis of gene expression changes during acute and chronic exposure to {Delta}9-THC in rats Physiol Genomics, September 8, 2000; 3(3): 175 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Sullivan Cellular and Molecular Mechanisms Underlying Learning and Memory Impairments Produced by Cannabinoids Learn. Mem., May 1, 2000; 7(3): 132 - 139. [Abstract] [Full Text]
|
|
|
|
|
|
A. F. Hoffman and C. R. Lupica Mechanisms of Cannabinoid Inhibition of GABAA Synaptic Transmission in the Hippocampus J. Neurosci., April 1, 2000; 20(7): 2470 - 2479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Katona, B. Sperlagh, A. Sik, A. Kafalvi, E. S. Vizi, K. Mackie, and T. F. Freund Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons J. Neurosci., June 1, 1999; 19(11): 4544 - 4558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Hampson, G. Rogers, G. Lynch, and S. A. Deadwyler Facilitative Effects of the Ampakine CX516 on Short-Term Memory in Rats: Enhancement of Delayed-Nonmatch-to-Sample Performance J. Neurosci., April 1, 1998; 18(7): 2740 - 2747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Hampson, G. Rogers, G. Lynch, and S. A. Deadwyler Facilitative Effects of the Ampakine CX516 on Short-Term Memory in Rats: Correlations with Hippocampal Neuronal Activity J. Neurosci., April 1, 1998; 18(7): 2748 - 2763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Brodkin and J. M. Moerschbaecher SR141716A Antagonizes the Disruptive Effects of Cannabinoid Ligands on Learning in Rats J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1526 - 1532. [Abstract] [Full Text]
|
|
|
|
|
|
L. J. Sim, R. E. Hampson, S. A. Deadwyler, and S. R. Childers Effects of Chronic Treatment with Delta 9-Tetrahydrocannabinol on Cannabinoid-Stimulated [35S]GTPgamma S Autoradiography in Rat Brain J. Neurosci., December 15, 1996; 16(24): 8057 - 8066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kim and S. A. Thayer Cannabinoids Inhibit the Formation of New Synapses between Hippocampal Neurons in Culture J. Neurosci., May 15, 2001; 21(10): RC146 - RC146. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
